APLs | APS patients N = 130 | All controls N = 58 | p value APS vs All controls | Healthy controls (HC) N = 40 | p value APS vs HC | Sepsis patients (SP) N = 18 | p value APS vs SP | |
---|---|---|---|---|---|---|---|---|
CL | IgM | 34 (26%) | 1 (2%) | 0.001 | 0 | < 0.001 | 1 (5%) | 0.07 |
IgG | 77 (59%) | 1 (2%) | 0.001 | 0 | < 0.001 | 1 (5%) | < 0.001 | |
P-acid | IgM | 17 (13%) | 0 | 0.001 | 0 | < 0.05 | 0 | NS |
IgG | 73 (56%) | 0 | 0.001 | 0 | < 0.001 | 0 | < 0.001 | |
PE | IgM | 4 (3%) | 0 | NS | 0 | NS | 0 | NS |
IgG | 3 (2%) | 0 | NS | 0 | NS | 0 | NS | |
PG | IgM | 4 (3%) | 0 | NS | 0 | NS | 0 | NS |
IgG | 50 (38%) | 0 | 0.001 | 0 | < 0.001 | 0 | < 0.001 | |
PI | IgM | 11 (8%) | 0 | 0.01 | 0 | 0.06 | 0 | NS |
IgG | 59 (45%) | 1 (2%) | 0.001 | 1 (2%) | < 0.001 | 0 | < 0.001 | |
PS | IgM | 16 (12%) | 0 | 0.003 | 0 | < 0.05 | 0 | NS |
IgG | 73 (56%) | 0 | 0.001 | 0 | < 0.001 | 0 | < 0.001 | |
AN | IgM | 2 (1%) | 1 (2%) | NS | 0 | NS | 1 (5%) | NS |
IgG | 36 (27%) | 5 (9%) | 0.003 | 2 (5%) | < 0.01 | 3 (16%) | NS | |
β2GP1 | IgM | 42 (32%) | 6 (10%) | 0.003 | 4 (10%) | < 0.001 | 2 (10%) | NS |
IgG | 86 (66%) | 5 (9%) | 0.001 | 1 (2%) | < 0.001 | 4 (22%) | < 0.001 | |
PT | IgM | 2 (1%) | 0 | NS | 0 | NS | 0 | NS |
IgG | 40 (30%) | 1 (2%) | 0.001 | 0 | < 0.001 | 1 (5%) | < 0.05 |